Synapse - Works

Results (2639)

Autologous stem cell transplant is a feasible treatment for older relapsed and refractory Hodgkin lymphoma patients

Meeting Abstract

Glick, H.; Lee, C.; Sauter, C. S.; Moskowitz, C. H.; Matasar, M. J.
Blood (2013)

Impact of induction regimen and consolidative stem cell transplantation in patients with double hit lymphoma (DHL): A large multicenter retrospective analysis

Meeting Abstract

Gandhi, M.; Petrich, A. M.; Cassaday, R. D.; Press, O. W.; Shah, K.; Whyman, J.; Lansigan, F.; Zelenetz, A. D.; Shah, N.; Fenske, T. S.; more...
Blood (2013)

Fulltext@MSK | Save

Extensive high-depth sequencing of longitudinal CLL samples identifies frequent mutations in MAP kinase signaling and novel mutations activating notch and beta-catenin

Meeting Abstract

Gardner, J. R.; Nahas, M. K.; He, J.; Patel, M.; Knapp, K. M.; Palomba, M. L.; Yelensky, R.; Donahue, A. L.; Otto, G. A.; Arcila, M.; more...
Blood (2013)

Fulltext@MSK | Save

Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ, in patients with chronic lymphocytic leukemia

Meeting Abstract

Flinn, I.; Patel, M.; Kahl, B. S.; Horwitz, S. M.; Foss, F. M.; Oki, Y.; Porcu, P.; Sweeney, J.; Allen, K.; Faia, K.; more...
Blood (2013)

Fulltext@MSK | Save

Eomesodermin regulates the early activation of alloreactive CD4 T cells and is critical for both Gvh and GVL responses

Meeting Abstract

Du Rocher, B.; Smith, O. M.; Intlekofer, A. M.; Dudakov, J. A.; Levy, E.; Kreiners, F.; Reiner, S.; Abdelhay, E.; van den Brink, M. R. M.; Hanash, A. M.
Blood (2013)

Fulltext@MSK | Save

Treatment with the potent PI3K-,δ,γ inhibitor IPI-145 is associated with rapid decreases in specific cytokines, chemokines and matrix metalloproteinases in the serum of patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma

Meeting Abstract

Douglas, M.; Allison, K.; Ted, S.; Allen, K.; Kahl, B. S.; Horwitz, S. M.; Flinn, I. W.; Kelly, P.; Stern, H. M.
Blood (2013)

Fulltext@MSK | Save

Clinical activity of idelalisib (GS-1101), a selective inhibitor of PI3Kδ, in phase 1 and 2 trials in chronic lymphocytic leukemia (CLL): Effect of del(17p)/TP53 mutation, del(11q), IGHV mutation, and NOTCH1 mutation

Meeting Abstract

Coutre, S. E.; Leonard, J. P.; Barrientos, J. C.; De Vos, S.; Flinn, I.; Furman, R. R.; Brown, J. R.; Wagner-Johnston, N.; Benson, D. M. Jr; Schreeder, M. T.; more...
Blood (2013)

Fulltext@MSK | Save

Early relapse of follicular lymphoma after R-CHOP uniquely defines patients at high risk for death: An analysis from the National LymphoCare Study

Meeting Abstract

Casulo, C.; Byrtek, M.; Dawson, K. L.; Zhou, X.; Farber, C.; Flowers, C. R.; Hainsworth, J. D.; Link, B. K.; Zelenetz, A. D.; Friedberg, J. W.
Blood (2013)

Fulltext@MSK | Save

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): Preliminary results from the t-cell consortium trial

Meeting Abstract

Advani, R. H.; Ansell, S. M.; Lechowicz, M. J.; Beaven, A. W.; Loberiza, F. R. Jr; Carson, K. R.; Evens, A. M.; Foss, F. M.; Horwitz, S. M.; Pro, B.; more...
Blood (2013)

Fulltext@MSK | Save

Impact of renal insufficiency and obesity on safety and outcomes of BEAM conditioning

Meeting Abstract

Afifi, S.; Adel, N. G.; Zhang, Z.; Shi, W.; Moskowitz, C. H.; Matasar, M. J.
Blood (2013)

Fulltext@MSK | Save